Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycling Topical Steroids in EoE
NCT05444543Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray, EPI-EE in eosinophilic esophagitis (EoE), sponsored by University Hospitals Cleveland Medical Center. Started Nov 2021; status: completed.
02
Drugs
fluticasone propionate nasal sprayEPI-EE
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT05444543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05444543.